|
Jul 26
|
Immunis to use MRI-based AI muscle analysis for sarcopenia trial
|
|
Jun 20
|
Biophytis grants Blanver Exclusive Rights to BIO101 in Latin America in Deal Valued at up to €108 Million
|
|
Jan 11
|
40 Cities with the Lowest Life Expectancy in the US
|
|
Sep 19
|
Biophytis Provides an Update on its Early Access Programs for Sarconeos (BIO101) in the Treatment of Severe Forms of COVID-19
|
|
Sep 14
|
Biophytis Strengthens its Management Team with the Appointment of its Chief Business Officer
|
|
Aug 8
|
Biophytis Receives a Positive Opinion for its SARA-31 Phase 3 Study in Sarcopenia in Europe
|